NCT06107023

Brief Summary

Multiple sclerosis is a chronic, autoimmune and inflammatory disease of the Central Nervous System characterized by neuronal demyelination and axonal degeneration. Upper extremity problems are present in MS patients from an early stage, affecting the performance of the individual and leading to a decrease in activity of daily living ability in proportion to the extent of the problem. Action Observation Training is currently being examined as one of the methods used for the improvement of motor disorders and has been shown in the literature to be effective on different functions in neurological diseases. The aim of this study was to investigate the effects of action observation training with 3D virtual reality on upper extremity functions, fatigue, cognitive functions, activities of daily living and quality of life in MS patients. Hypothesis 1: Action observation training with 3D virtual reality has an effect on upper extremity functions in MS patients. Hypothesis 2: Action observation training with 3D virtual reality has an effect on cognitive function in MS patients. Hypothesis 3: Action observation training with 3D virtual reality has an effect on fatigue in MS patients. Hypothesis 4: Action observation training with 3D virtual reality has an effect on activities of daily living in MS patients. Hypothesis 5: Action observation training with 3D virtual reality has an effect on quality of life in MS patients.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
32

participants targeted

Target at P25-P50 for not_applicable multiple-sclerosis

Timeline
Completed

Started Nov 2023

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

October 18, 2023

Completed
12 days until next milestone

First Posted

Study publicly available on registry

October 30, 2023

Completed
16 days until next milestone

Study Start

First participant enrolled

November 15, 2023

Completed
1.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 2, 2025

Completed
28 days until next milestone

Study Completion

Last participant's last visit for all outcomes

March 2, 2025

Completed
Last Updated

January 28, 2026

Status Verified

January 1, 2025

Enrollment Period

1.2 years

First QC Date

October 18, 2023

Last Update Submit

January 27, 2026

Conditions

Keywords

multiple sclerosismotor learningaction observation trainingvirtual realityupper extremity function

Outcome Measures

Primary Outcomes (3)

  • Box and Block Test

    upper extremity function assessment

    baseline and 6th week

  • nine hole peg test

    upper extremity function assessment

    baseline and 6th week

  • hand dynamometer

    grip strength assessment

    baseline and 6th week

Secondary Outcomes (4)

  • Fatigue severity scale

    baseline and 6th week

  • Paced Auditory Serial Addition Test

    baseline and 6th week

  • The Arm Function in Multiple Sclerosis Questionnaire

    baseline and 6th week

  • Multiple Sclerosis Quality of Life-54

    baseline and 6th week

Study Arms (2)

Intervention Group

EXPERIMENTAL

action observation and upper extremity activities

Behavioral: Action observation training

Control Group

SHAM COMPARATOR

sham action observation and upper extremity activities

Behavioral: sham action observation training

Interventions

6 weeks, three days a week.

Intervention Group

6 weeks, three days a week.

Control Group

Eligibility Criteria

Age18 Years - 65 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • \< 2 years MS diagnosis according to McDonald criteria
  • between 3.5 and 6 the EDSS
  • Nine Hole Peg Test \> 30s for at least one upper extremity
  • no change in medication in the last 6 months
  • having MS disease with ongoing attacks
  • \>2 Modified Ashworth Scale in the upper extremities
  • MOCA\>25

You may not qualify if:

  • diagnosed with neurological (except MS), cardiopulmonary, metabolic or musculoskeletal disease that would prevent treatment and evaluation
  • receiving botulinum toxin treatment in the last 6 months
  • visual impairment uncorrected by optical devices
  • inability to adapt to treatment based on 3D immersive virtual reality (e.g. with cognitive impairment, communication problems, psychological problems or vestibular system problems)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Izzet Baysal University

Bolu, Center, 14030, Turkey (Türkiye)

Location

Related Publications (6)

  • Bunday KL, Lemon RN, Kilner JM, Davare M, Orban GA. Grasp-specific motor resonance is influenced by the visibility of the observed actor. Cortex. 2016 Nov;84:43-54. doi: 10.1016/j.cortex.2016.09.002. Epub 2016 Sep 11.

    PMID: 27697663BACKGROUND
  • Choi JW, Kim BH, Huh S, Jo S. Observing Actions Through Immersive Virtual Reality Enhances Motor Imagery Training. IEEE Trans Neural Syst Rehabil Eng. 2020 Jul;28(7):1614-1622. doi: 10.1109/TNSRE.2020.2998123.

    PMID: 32634098BACKGROUND
  • Rocca MA, Meani A, Fumagalli S, Pagani E, Gatti R, Martinelli-Boneschi F, Esposito F, Preziosa P, Cordani C, Comi G, Filippi M. Functional and structural plasticity following action observation training in multiple sclerosis. Mult Scler. 2019 Oct;25(11):1472-1487. doi: 10.1177/1352458518792771. Epub 2018 Aug 7.

    PMID: 30084706BACKGROUND
  • Sollfrank T, Hart D, Goodsell R, Foster J, Tan T. 3D visualization of movements can amplify motor cortex activation during subsequent motor imagery. Front Hum Neurosci. 2015 Aug 20;9:463. doi: 10.3389/fnhum.2015.00463. eCollection 2015.

    PMID: 26347642BACKGROUND
  • Yoshimura M, Kurumadani H, Hirata J, Osaka H, Senoo K, Date S, Ueda A, Ishii Y, Kinoshita S, Hanayama K, Sunagawa T. Virtual reality-based action observation facilitates the acquisition of body-powered prosthetic control skills. J Neuroeng Rehabil. 2020 Aug 20;17(1):113. doi: 10.1186/s12984-020-00743-w.

    PMID: 32819412BACKGROUND
  • Yu JA, Park J. The effect of first-person perspective action observation training on upper extremity function and activity of daily living of chronic stroke patients. Brain Behav. 2022 May;12(5):e2565. doi: 10.1002/brb3.2565. Epub 2022 Apr 10.

    PMID: 35398981BACKGROUND

MeSH Terms

Conditions

Multiple Sclerosis

Condition Hierarchy (Ancestors)

Demyelinating Autoimmune Diseases, CNSAutoimmune Diseases of the Nervous SystemNervous System DiseasesDemyelinating DiseasesAutoimmune DiseasesImmune System Diseases

Study Officials

  • Tuba Kaya Benli, MSc

    Abant Izzet Baysal University

    PRINCIPAL INVESTIGATOR
  • Yeşim Bakar, Prof. Dr.

    Izmir Bakircay University

    STUDY DIRECTOR
  • Şule Aydın Türkoğlu, Assoc. Prof.

    Abant Izzet Baysal University

    STUDY CHAIR
  • Enes Tayyip Benli, MSc

    Abant Izzet Baysal University

    STUDY CHAIR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
lecturery

Study Record Dates

First Submitted

October 18, 2023

First Posted

October 30, 2023

Study Start

November 15, 2023

Primary Completion

February 2, 2025

Study Completion

March 2, 2025

Last Updated

January 28, 2026

Record last verified: 2025-01

Data Sharing

IPD Sharing
Will not share

Locations